Ewing Sarcoma New Diagnosis
Ewing Sarcoma New Diagnosis
FAPI-1301: 64Cu-LNTH-1363S in Patients with Sarcoma or Gastrointestinal Tract Cancer (PHANTOM)
- Ages: 18 Years and older
This is a multicenter, open-label, prospective Phase 1/2a study to assess safety and tolerability, establish dosimetry and to identify an optimal imaging dose (radioactivity and mass dose) and imaging time window of 64Cu-LNTH-1363S (64Cu Radiolabeled FAPi PET/CT Imaging Agent) and to compare its ima ...More
Single arm evaluation of romiplostim to prevent chemotherapy induced thrombocytopenia in patients with Ewing sarcoma.
- Ages: >1 year old
This is a single-arm, multi-center clinical trial to assess the efficacy of romiplostim as a supportive care measure in patients with a new diagnosis of Ewing sarcoma receiving interval-compressed chemotherapy. Romiplostim-BT-2201: Single arm evaluation of romiplostim to prevent chemotherapy induce ...More
Contact Us
To learn more about available sarcoma clinical trials, contact us at cancer@cchmc.org or 513-636-2799.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
